1. Home
  2. GRFS vs FNB Comparison

GRFS vs FNB Comparison

Compare GRFS & FNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.92

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Logo F.N.B. Corporation

FNB

F.N.B. Corporation

HOLD

Current Price

$16.92

Market Cap

6.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
FNB
Founded
1940
1864
Country
Spain
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
6.0B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
GRFS
FNB
Price
$8.92
$16.92
Analyst Decision
Hold
Strong Buy
Analyst Count
1
8
Target Price
$10.30
$18.31
AVG Volume (30 Days)
667.0K
5.0M
Earning Date
01-01-0001
01-21-2026
Dividend Yield
1.60%
2.84%
EPS Growth
N/A
28.48
EPS
0.64
1.40
Revenue
$8,821,017,248.00
$1,587,400,000.00
Revenue This Year
$5.46
$17.82
Revenue Next Year
$5.60
$8.12
P/E Ratio
$17.34
$12.09
Revenue Growth
7.31
6.34
52 Week Low
$6.19
$10.88
52 Week High
$11.14
$17.05

Technical Indicators

Market Signals
Indicator
GRFS
FNB
Relative Strength Index (RSI) 52.15 66.14
Support Level $7.64 $16.34
Resistance Level $8.90 $16.85
Average True Range (ATR) 0.27 0.39
MACD 0.07 0.10
Stochastic Oscillator 92.00 93.21

Price Performance

Historical Comparison
GRFS
FNB

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About FNB F.N.B. Corporation

F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.

Share on Social Networks: